HSD17B13 and hepatocellular carcinoma: Among patients with HSD17B13 variants, the HCC risk was reduced in those with a FIB‐4 index <2.67, normal body weight, and normal lipid levels; conversely, the HCC risk was increased in patients with diabetes mellitus and hypertension among those with the HSD17B13 A/A genotype.